Introduction: Jinlida started to set foot in China medical e-commerce from 20 1 1. It is a third-party B2B platform enterprise approved by China Food and Drug Administration, a national high-tech enterprise, and has become the leader of pharmaceutical e-commerce in China. Jinlida has been committed to the software development of third-party Internet drug bidding and Internet drug trading services, and its business has covered the whole country.
Legal Representative: Miao.
Established: 2011-06-01.
Registered capital: 50 million yuan.
Industrial and commercial registration number: 3605042 10002957
Type of enterprise: limited liability company (Taiwan, Hong Kong and Macao joint venture)
Company address: No.2951Yudong Avenue, High-tech Development Zone, Xinyu City, Jiangxi Province